JBS N.V. (NYSE: JBS) reported a second-quarter net loss of $102 million against a record revenue of $24 billion. The reported loss was driven by significant non-recurring charges, while adjusted net income remained positive at $218 million.

The global protein processor announced a strategic partnership with Mantra Investment Management, securing a $2.5 billion equity investment for a 25% stake in its Australia and New Zealand operations. This deal aims to fund growth initiatives in Southeast Asia.

Financial Performance

JBS delivered its highest-ever quarterly sales, reflecting strong volume and pricing dynamics across key markets. However, profitability metrics diverged significantly between reported GAAP/IFRS figures and adjusted operational results.

The reported net loss included a $319 million increase in net financial expenses. Key drivers were $172 million in costs related to the tender offer for bonds and Brazilian local debentures, alongside an $81 million bargain purchase gain adjustment from the Montrique Elementos acquisition and $133 million in antitrust settlements. Excluding these items, adjusted earnings per share reached $0.20.

Regional Operations

Brazil emerged as a standout performer, recording its highest-ever second-quarter EBITDA of $269 million (5.9% margin). This result was fueled by robust export demand, particularly to China, and disciplined commercial execution despite elevated cattle prices. The domestic business also benefited from strong performance in the barbecue portfolio and expanded retailer partnerships.

In contrast, the U.S. Beef segment continues to face headwinds from tight cattle supplies and historically high input costs. However, operational improvements helped narrow the EBITDA margin deficit to -1.3%, up from -3.9% in the prior year. U.S. Pork demonstrated resilience with an EBITDA margin expansion to 8.9% from 6.5% year-over-year, despite weaker demand in prepared foods.

Australia’s results improved amid challenging supply conditions caused by drought-related constraints on cattle availability. The upcoming joint venture with Mantra is expected to unlock up to $5 billion in funding capacity for acquisitions and greenfield projects in Indonesia and Southeast Asia.

What the Numbers Show

A critical divergence exists between JBS’s top-line momentum and its bottom-line pressure. While revenue hit a record $24 billion, adjusted EBITDA declined by $324 million year-over-year. This gap highlights that current profitability is being sustained by margin protection and efficiency gains rather than pure volume leverage. Furthermore, free cash flow improved by $105 million to $130 million, primarily due to working capital management—specifically higher receivable discounts and advanced payments from Chinese customers—offsetting the decline in operating cash generation.

Balance Sheet and Outlook

Free cash flow generation strengthened despite the drop in adjusted EBITDA, aided by lower tax payments of $135 million year-over-year. Total capital expenditures rose by $163 million, largely driven by expansion projects.

Net leverage ended the quarter at 3.1 times, slightly above the long-term target range of 2-3 times. The company highlighted that it has no significant debt maturities until 2031, with an average debt term of 15.3 years and an average cost of 5.7%. Management expects leverage to remain slightly elevated in the near term as it focuses on cash generation and disciplined capital allocation for the remainder of FY26.

JBS (NYSE: JBS) reported quarterly adjusted earnings of $0.20 per share for the second quarter, missing the analyst consensus estimate of $0.32 by 37.5 percent. This result represents a 58.33 percent decrease from the $0.48 per share earnings recorded in the same period last year. The divergence between the earnings miss and revenue performance highlights margin pressures impacting the bottom line despite robust sales growth.

On the top line, JBS demonstrated strong operational momentum, reporting quarterly sales of $23.899 billion. This figure beat the analyst consensus estimate of $22.903 billion by 4.35 percent. The sales performance also showed a massive year-over-year expansion, rising from $20.998 million in the same period last year to the current quarter’s total.

Financial Performance Overview

The company’s financial results present a mixed picture, with revenue growth failing to translate into expected net profit due to the drop in earnings per share against estimates.

What the Numbers Show

The most striking aspect of JBS’s Q2 report is the extreme discrepancy in the year-over-year sales growth figure. While the absolute increase from $20.998 million to $23.899 billion is substantial in dollar terms, the source cites a 113.72K percent increase. This suggests a potential data anomaly in the prior year’s baseline or a structural change in reporting scope that drastically altered the comparability of the figures. Investors should note that while the revenue beat was clear against estimates, the profitability decline—shifting from higher prior-year earnings to a miss on current estimates—indicates cost headwinds or operational inefficiencies that outweighed the top-line gains.